Used as a key intermediate in the synthesis of fluoroquinolone antibiotics, this compound contributes to the development of antimicrobial agents with enhanced activity against resistant bacterial strains. Its structure supports the optimization of pharmacokinetic properties in final drug formulations. It is also employed in research settings for developing novel kinase inhibitors and other biologically active quinoline derivatives. The presence of the trifluoromethyl and hydroxy groups allows for further chemical modifications, making it valuable in medicinal chemistry and pharmaceutical development.